![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 ACS Appl Mater Interfaces |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Hyaluronic Acid-Conjugated Fluorescent Probe-Shielded Polydopamine Nanomedicines
for Targeted Imaging and Chemotherapy of Bladder Cancer.
ACS Appl Mater Interfaces. 2023 Sep 28. doi: 10.1021/acsami.3c09564.
PubMed
Abstract available
Elevating Second Near-Infrared Photothermal Conversion Efficiency of Hollow Gold
Nanorod for a Precise Theranostic of Orthotopic Bladder Cancer.
ACS Nano. 2023 Sep 28. doi: 10.1021/acsnano.3c04175.
PubMed
Abstract available
Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in
Recurrent Bladder Cancer.
Adv Sci (Weinh). 2023 Sep 24:e2303230. doi: 10.1002/advs.202303230.
PubMed
Abstract available
Reply to Letter to Editor: Cancer-Specific Mortality of Non-Muscle-Invasive
Bladder Cancer.
Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14360.
PubMed
Analysis of Transferrin in the Urine of Patients with Bladder Cancer Using
Nanobodies.
Biochemistry (Mosc). 2023;88:1105-1115.
PubMed
Abstract available
Association of metabolic syndrome and its components with the risk of urologic
cancers: a prospective cohort study.
BMC Urol. 2023;23:150.
PubMed
Abstract available
SQLE Knockdown inhibits bladder cancer progression by regulating the
PTEN/AKT/GSK3beta signaling pathway through P53.
Cancer Cell Int. 2023;23:221.
PubMed
Abstract available
FGFR3 alterations in bladder cancer stimulate serine synthesis to induce
immune-inert macrophages that suppress T-cell recruitment and activation.
Cancer Res. 2023 Sep 28. doi: 10.1158/0008-5472.CAN-23-1065.
PubMed
Abstract available
Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A
Systematic Review.
Cancers (Basel). 2023;15:4518.
PubMed
Abstract available
Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through
deregulated microtubule and actin dynamics.
Cell Mol Life Sci. 2023;80:299.
PubMed
Abstract available
DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK
signaling pathways through PTPN7.
Cell Signal. 2023;112:110893.
PubMed
Abstract available
Inhibition of autophagy can promote the apoptosis of bladder cancer cells induced
by SC66 through the endoplasmic reticulum stress pathway.
Chem Biol Interact. 2023 Sep 21:110725. doi: 10.1016/j.cbi.2023.110725.
PubMed
Abstract available
Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for
Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective
Clinical Study.
Clin Genitourin Cancer. 2023 Aug 10:S1558-7673(23)00186.
PubMed
Abstract available
Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk
Non-muscle Invasive Bladder Cancer.
Cureus. 2023;15:e45672.
PubMed
Abstract available
Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in
a Patient with Urothelial Cancer.
Curr Oncol. 2023;30:7802-7809.
PubMed
Abstract available
MCM4 expression is associated with high-grade histology, tumor progression and
poor prognosis in urothelial carcinoma.
Diagn Pathol. 2023;18:106.
PubMed
Abstract available
Intracellular Gemcitabine Monophosphate Levels Predict Chemotherapy Efficacy in
Gemcitabine-Treated Patients with Bladder Cancer.
Dokl Biochem Biophys. 2023 Sep 29. doi: 10.1134/S1607672923700503.
PubMed
Abstract available
Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer:
the present and the future.
Expert Rev Anticancer Ther. 2023 Sep 27:1-13. doi: 10.1080/14737140.2023.2257389
PubMed
Abstract available
GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin
Resistance in Bladder Cancer.
Int J Mol Sci. 2023;24:13733.
PubMed
Abstract available
Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer
and FDA-Approved Biomarkers.
Int J Mol Sci. 2023;24:14374.
PubMed
Abstract available
Editorial Comment to Impact on Japanese healthcare economics of photodynamic
diagnosis-assisted transurethral resection of bladder tumor for non-muscle
invasive bladder cancer: A multicenter retrospective cohort study.
Int J Urol. 2023 Sep 22. doi: 10.1111/iju.15308.
PubMed
Editorial Comment to "Improving compliance with guidelines may lead to favorable
clinical outcomes for patients with non-muscle-invasive bladder cancer: A
retrospective multicenter study".
Int J Urol. 2023 Sep 27. doi: 10.1111/iju.15311.
PubMed
Development of a prognostic signature for immune-associated genes in bladder
cancer and exploring potential drug findings.
Int Urol Nephrol. 2023 Sep 23. doi: 10.1007/s11255-023-03796.
PubMed
Abstract available
Identifying possible hub genes and biological mechanisms shared between bladder
cancer and inflammatory bowel disease using machine learning and integrated
bioinformatics.
J Cancer Res Clin Oncol. 2023 Sep 23. doi: 10.1007/s00432-023-05266.
PubMed
Abstract available
Radiomic Analysis of Quantitative T2 Mapping and Conventional MRI in Predicting
Histologic Grade of Bladder Cancer.
J Clin Med. 2023;12:5900.
PubMed
Abstract available
The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer
before and after Cystectomy Depending on Blood Group and Neoadjuvant
Chemotherapy-A Multicentre Retrospective Cohort Study.
J Pers Med. 2023;13:1355.
PubMed
Abstract available
Bladder Cancer during Pregnancy: A Review of the Literature.
J Pers Med. 2023;13:1418.
PubMed
Abstract available
Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates
bladder cancer progression.
J Transl Med. 2023;21:656.
PubMed
Abstract available
Primary Chemoablation for Intermediate-Risk Low-Grade Bladder Cancer: New
Paradigm or Added Uncertainty? Letter.
J Urol. 2023 Sep 28:101097JU0000000000003729. doi: 10.1097/JU.0000000000003729.
PubMed
Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New
Paradigm or Added Uncertainty?
J Urol. 2023 Sep 27:101097JU0000000000003702. doi: 10.1097/JU.0000000000003702.
PubMed
Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical
Cystectomy Is Prognostic but Not Therapeutic. Reply.
J Urol. 2023 Sep 25:101097JU0000000000003704. doi: 10.1097/JU.0000000000003704.
PubMed
Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical
Cystectomy Is Prognostic but Not Therapeutic. Reply.
J Urol. 2023 Sep 25:101097JU0000000000003705. doi: 10.1097/JU.0000000000003705.
PubMed
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in
Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical
Trial.
JAMA Oncol. 2023;9:1205-1213.
PubMed
Abstract available
Predicting Survival Signature of Bladder Cancer Related to Cancer-Associated
Fibroblast (CAF) Constructed by Intersecting Genes in TCGA and GEO.
Mol Biotechnol. 2023 Sep 25. doi: 10.1007/s12033-023-00892.
PubMed
Abstract available
Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder
cancer progression through the WNT pathway.
Pharmacol Res. 2023 Sep 25:106940. doi: 10.1016/j.phrs.2023.106940.
PubMed
Abstract available
Self-reported sleep disorders and the risk of all cancer types: evidence from the
Kailuan Cohort study.
Public Health. 2023;223:209-216.
PubMed
Abstract available
Health-related quality of life prior to and 1 year after radical cystectomy
evaluated with FACT-G and FACT-VCI questionnaires.
Scand J Urol. 2023;58:76-83.
PubMed
Abstract available
Author Correction: Synthetic Tet-inducible artificial microRNAs targeting
beta-catenin or HIF-1alpha inhibit malignant phenotypes of bladder cancer cells T24 and
5637.
Sci Rep. 2023;13:16331.
PubMed
Acute Kidney Injury within 90 days of Radical Cystectomy for Bladder Cancer:
Incidence and Risk Factors.
Urology. 2023 Sep 22:S0090-4295(23)00807-5. doi: 10.1016/j.urology.2023.
PubMed
Abstract available
Microbial trends in infection-related readmissions following radical cystectomy
for bladder cancer.
Urology. 2023 Sep 22:S0090-4295(23)00805-1. doi: 10.1016/j.urology.2023.
PubMed
Abstract available
Mycotic Abdominal Aortic Aneurysm Secondary to BCG Therapy for Non-muscle
Invasive Urothelial Carcinoma of the Bladder.
Vasc Endovascular Surg. 2023;57:776-780.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by